Centaurus Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,800
| Closed | -$114K | – | 878 |
|
|
2024
Q2 | $114K | Buy |
+2,800
| New | +$114K | 0.01% | 752 |
|
|
2024
Q1 | – | Sell |
-2,800
| Closed | -$119K | – | 867 |
|
|
2023
Q4 | $119K | Buy |
+2,800
| New | +$119K | 0.01% | 716 |
|
|
2022
Q2 | – | Sell |
-3,000
| Closed | -$105K | – | 946 |
|
|
2022
Q1 | $105K | Buy |
+3,000
| New | +$105K | 0.01% | 855 |
|